ePharmaSolutions Launches New Application to Streamline Single Sign-On and User Account Provisioning for Sponsors Using Multiple Clinical Trial Technologies
One of the more cumbersome tasks for study teams is to manage the user administration and provisioning process into all of the technologies used to conduct clinical trials today. ePharmaSolutions has developed a solution to streamline this process to one set of credentials and one technology solution regardless of the number of vendors involved in a given study.
"The Vendor Integration Manager (VIM) is now being used on dozens of studies and provides study teams with a single user interface to manage the user provisioning process," stated Lance Converse, ePharmaSolutions founder and CEO. "Our clients complained about the need to complete up to 10 different spreadsheets each time a user is added or edited through the study, which on large studies is a difficult task that is ridden with errors," Converse added.
A typical clinical study can require up to 10 unique technology vendors that each has their own account activation and user provisioning forms and processes. This is cumbersome for clinical study managers conducting large studies who are required to complete these forms each time a user is added or edited throughout a study. For larger studies, access control to as many as 4,000 unique users in 10 systems with different roles and naming conventions must be maintained and updated in a validated environment.
"The Vendor Integration Manager works as the system of record for each user in the study and auto-completes each technology vendor's user account provisioning forms in the exact format and process they require saving study teams an enormous amount of time and avoiding countless mistakes," Converse said.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
